• Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatments

    Thursday July 1st 2021

  • Novalis Biotech closes €25 million Biotech Acceleration Fund

    Wednesday June 30th 2021

  • Biotalys launches its Initial Public Offering on Euronext Brussels

    Wednesday June 23rd 2021

  • Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

    Tuesday June 22nd 2021

  • Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels

    Tuesday June 15th 2021

  • Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics

    Monday June 14th 2021

  • RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV

    Wednesday June 2nd 2021

  • Investment in Flow Cytometry unlocks the secrets of single cells

    Thursday May 20th 2021

  • Your news here?

  • Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

    Tuesday May 11th 2021

  • Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance

    Tuesday May 11th 2021

  • Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test

    Tuesday April 20th 2021


Strategic Partners